AIM
INSY

Advantage Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Advantage Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-105
Closed – – 987
2019
Q2 		$0 Hold
105
– – ﹤0.01% 983
2019
Q1 		$0 Hold
105
– – ﹤0.01% 1039
2018
Q4 		$0 Hold
105
– – ﹤0.01% 1119
2018
Q3 		$1K Buy
+105
New +$838 ﹤0.01% 998

Advantage Investment Management's INSY Position: Q3 2019 in Review

Advantage Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 105 shares.

Advantage Investment Management first reported a position in INSY in Q3 2018 and held it in 4 quarters. The position peaked at $1K in Q3 2018. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

  • Advantage Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Advantage Investment Management sold 105 Insys Therapeutics, Inc. shares in Q3 2019.
  • Advantage Investment Management first reported a position in Insys Therapeutics, Inc. in Q3 2018 and held it in 4 quarters.
  • Advantage Investment Management's Insys Therapeutics, Inc. position peaked at $1K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.